comparemela.com

Latest Breaking News On - Pharma analyst - Page 1 : comparemela.com

Climate Change Fuels Surge in Multiple Sclerosis Cases

Climate change-induced exacerbations will increase the number of multiple sclerosis cases.

Sanofi-aubagio
Jos-opdenakker
Novartis
Genentech
Pharma-analyst
Compare-new
Existing-standards-globaldata
Pharma-intelligence-center

GlobalData : Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData

24 May, 2024 Innovent Biologics mazdutide can pave way for transformative T2D treatment, says GlobalData Share Print page .

China
Chinese
Eli-lilly
Innovent-biologics
Nelluri-geetha
Innovent-biologics-inc
Globaldata-pharmaceutical-intelligence-center
Pharmaceutical-intelligence-center
Pharma-analyst

Diabetes and Obesity Market of GLP-1 Drugs Will Be $125 Billion By 2033!

GLP-1 drugs, the marvel drugs, in recent decades, have led the market significantly, with a market projection of $125 billion by 2033.

United-kingdom
Italy
Japan
Germany
Spain
France
Ozempic-wegovy
Costanza-alciati
Lilly-mounjaro
Novo-nordisk
Market-forecast
Market-analysis

Roche's therapy shows promise in slowing Parkinson's disease motor progression: GlobalData - Pharma News

Roche's therapy shows promise in slowing Parkinson's disease motor progression: GlobalData - Pharma News
financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.

United-states
American
Lorraine-palmer
Parkinson-progression-marker-initiative
American-academy-of-neurology
American-academy
Progression-marker-initiative
Pharma-analyst
Colorectal-cancer

GlobalData : Roche's PRX-002 shows promise in slowing Parkinson's disease motor progression, says GlobalData

19 Apr, 2024 Roche s PRX-002 shows promise in slowing Parkinson s disease motor progression, says GlobalData Share Print.

United-states
American
Lorraine-palmer
Parkinson-progression-marker-initiative
Movement-disorder-society
American-academy-of-neurology
American-academy
Pharma-analyst
Progression-marker-initiative
Movement-disorder-society-sponsored-revision
Unified-parkinson
Disease-rating-scale

vimarsana © 2020. All Rights Reserved.